A phantom-based analysis for tracking intra-fraction pancreatic tumor motion by ultrasound imaging during radiation therapy

Tianlong Ji, Ziwei Feng, Edward Sun, Sook Kien Ng, Lin Su, Yin Zhang⋆, Dong Han, S. Han-Oh, Iulian Iordachita, Junghoon Lee, Peter Kazanzides, Muyinatu A. Lediju Bell, John Wong, Kai DingFrontiers in Oncology 2022 · DOI

Abstract

Purpose: This study evaluates the accuracy of ultrasound (US) tracking for intra-fraction pancreatic tumor motion during radiotherapy using a phantom-based model. Methods: Respiratory cycle data from 12 pancreatic cancer patients (treated with SBRT) were acquired via 4DCT and transferred to a motion platform. An abdominal phantom was fixed to the platform, and its ground truth motion was recorded using an infrared (IR) optical tracker. An ultrasound system tracked a target tumor within the phantom, and results were compared against the IR data using root-mean-square error (RMSE). Results: 82.2% of US tracking measurements were within 0.5 mm of the IR ground truth, with only 0.7% failing (error > 2.5 mm). Tracking accuracy showed no correlation with respiratory displacement, velocity, or acceleration. Conclusions: The high accuracy demonstrated suggests that US tracking is a viable method for real-time target monitoring, potentially improving radiation dose delivery precision.

Introduction

Pancreatic cancer treatment often involves high-dose Stereotactic Body Radiation Therapy (SBRT). However, the pancreas is subject to significant intra-fraction motion due to respiration, moving up to 24 mm. To ensure target coverage, clinicians typically use large Planning Target Volumes (PTVs) of 15–30 mm. While effective, these large margins increase radiation exposure to adjacent critical organs like the stomach and duodenum, leading to toxicity.

Non-invasive, real-time tracking is essential to reduce these margins. While MRI-guided systems are costly and X-ray-based systems involve additional ionizing radiation, ultrasound offers a cost-effective, non-ionizing alternative with high soft-tissue contrast. This study validates a US-based tracking system using a realistic phantom setup.

Methods and Materials

The researchers developed a sophisticated phantom-based experimental setup to simulate clinical conditions accurately.

Motion Simulation and Phantom

Instead of idealized waveforms, the study used actual respiratory displacement data from 4DCT scans of 12 pancreatic cancer patients. This data drove a motion platform carrying an ABDFAN ultrasound abdominal phantom (Kyoto Kagaku Co, Japan), which contains simulated organ structures and tumors.

Tracking and Validation

A 4D convex ultrasound probe (3-7 MHz) was held against the phantom using a customized "arm-bridge" mechanical system. The tracking algorithm employed intensity-based image-to-image registration, comparing real-time US frames to a manually contoured reference image. Ground truth was established using an external infrared (IR) camera system tracking an optical marker on the phantom.

Figure 1: (A) The experimental setup showing the motion platform, phantom, and ultrasound scanner. (B) Example of real-time ultrasound tracking with a red target contour. (C) Reference ultrasound image with a manually contoured green target.

Key Results

The system demonstrated exceptional precision and reliability across the simulated patient profiles:

  • Sub-millimeter Accuracy: 82.2% of all tracking points were within 0.5 mm of the ground truth.
  • Clinical Reliability: Only 0.7% of points exceeded the 2.5 mm clinical failure threshold.
  • Strong Correlation: Linear regression analysis showed a near-perfect correlation ($r \approx 1.0$) between US-tracked and IR-monitored motion for all patients.
  • Dynamic Stability: Tracking errors did not correlate with respiratory velocity or acceleration, indicating the algorithm remains stable even during irregular breathing patterns.

One outlier, "Patient 4," showed a slightly higher RMSE (1.121 mm), likely due to a very short respiratory cycle (1.37s), which may test the temporal resolution limits of the current system.

Discussion and Limitations

While these results are promising, several factors must be addressed before full clinical implementation:

  1. Deformable Anatomy: The rigid phantom used does not account for the abdominal deformation and organ compression that occurs in live patients under the pressure of a US probe.
  2. Motion Dimensions: This study focused on Superior-Inferior (SI) motion. Future work must evaluate tracking in the Left-Right (LR) and Anterior-Posterior (AP) directions.
  3. Acoustic Windows: Patient-specific factors like BMI and bowel gas can degrade US image quality, a challenge less prevalent in phantom studies.

Conclusion

This phantom-based study confirms that ultrasound tracking can monitor pancreatic tumor motion with high accuracy. By providing real-time, non-ionizing feedback, this technology could enable clinicians to reduce safety margins, thereby sparing healthy tissue and allowing for more aggressive dose escalation in pancreatic cancer treatment.

Summary updated

Abstract

Purpose In this study, we aim to further evaluate the accuracy of ultrasound tracking for intra-fraction pancreatic tumor motion during radiotherapy by a phantom-based study. Methods Twelve patients with pancreatic cancer who were treated with stereotactic body radiation therapy were enrolled in this study. The displacement points of the respiratory cycle were acquired from 4DCT and transferred to a motion platform to mimic realistic breathing movements in our phantom study. An ultrasound abdominal phantom was placed and fixed in the motion platform. The ground truth of phantom movement was recorded by tracking an optical tracker attached to this phantom. One tumor inside the phantom was the tracking target. In the evaluation of the results, the monitoring results from the ultrasound system were compared with the phantom motion results from the infrared camera. Differences between infrared monitoring motion and ultrasound tracking motion were analyzed by calculating the root-mean-square error. Results The 82.2% ultrasound tracking motion was within a 0.5 mm difference value between ultrasound tracking displacement and infrared monitoring motion. 0.7% ultrasound tracking failed to track accurately (a difference value > 2.5 mm). These differences between ultrasound tracking motion and infrared monitored motion do not correlate with respiratory displacements, respiratory velocity, or respiratory acceleration by linear regression analysis. Conclusions The highly accurate monitoring results of this phantom study prove that the ultrasound tracking system may be a potential method for real-time monitoring targets, allowing more accurate delivery of radiation doses.
BibTeX
@inproceedings{ji2022phantom,
  author = {Tianlong Ji and Ziwei Feng and Edward Sun and Sook Kien Ng and Lin Su and Yin Zhang⋆ and Dong Han and S. Han-Oh and Iulian Iordachita and Junghoon Lee and Peter Kazanzides and Muyinatu A. Lediju Bell and John Wong and Kai Ding},
  title = {{A phantom-based analysis for tracking intra-fraction pancreatic tumor motion by ultrasound imaging during radiation therapy}},
  booktitle = {Frontiers in Oncology},
  year = {2022},
  doi = {10.3389/fonc.2022.996537},
}
Figure